Neurological Complications during Treatment of Middle East Respiratory Syndrome
Open Access
- 1 January 2017
- journal article
- Published by Korean Neurological Association in Journal of Clinical Neurology
- Vol. 13 (3), 227-233
- https://doi.org/10.3988/jcn.2017.13.3.227
Abstract
Kim JE, et al. J Clin Neurol. 2017 Jul;13(3):227-233. https://doi.org/10.3988/jcn.2017.13.3.227Keywords
This publication has 28 references indexed in Scilit:
- Differential Cell Line Susceptibility to the Emerging Novel Human Betacoronavirus 2c EMC/2012: Implications for Disease Pathogenesis and Clinical ManifestationThe Journal of Infectious Diseases, 2013
- State of Knowledge and Data Gaps of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in HumansPLoS Currents, 2013
- Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysisThe Lancet Neurology, 2011
- EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathyEuropean Journal of Neurology, 2010
- Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathyAnnals of Neurology, 2008
- Acute inflammatory demyelinating polyneuropathy associated with pegylated interferon α 2a therapy for chronic hepatitis C virus infectionWorld Journal of Gastroenterology, 2008
- Peripheral neurotoxicity of pegylated interferon alphaNeurology, 2006
- A Prediction Rule to Identify Low-Risk Patients with Community-Acquired PneumoniaThe New England Journal of Medicine, 1997
- A New Simplified Acute Physiology Score (SAPS II) Based on a European/North American Multicenter StudyJAMA, 1993
- A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter studyJAMA, 1993